Biogen Idec (BIIB)

Add to Watchlists Create an Alert
232.77 +1.44  +0.62%   NASDAQ May 22, 4:59PM BATS Real time Currency in USD

Biogen Idec Cash from Investing Quarterly:

155.94M for March 31, 2013
View Full Chart

Biogen Idec Cash from Investing Quarterly Chart

    Biogen Idec Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 155.94M
    Dec. 31, 2012 -375.45M
    Sept. 30, 2012 -522.39M
    June 30, 2012 -53.12M
    March 31, 2012 0.618M
    Dec. 31, 2011 -389.53M
    Sept. 30, 2011 -587.18M
    June 30, 2011 -546.79M
    March 31, 2011 -126.80M
    Dec. 31, 2010 -518.62M
    Sept. 30, 2010 -69.75M
       
    June 30, 2010 683.96M
    March 31, 2010 249.74M
    Dec. 31, 2009 382.62M
    Sept. 30, 2009 -474.43M
    June 30, 2009 -211.51M
    March 31, 2009 -91.71M
    Dec. 31, 2008 -465.76M
    Sept. 30, 2008 -99.47M
    June 30, 2008 -250.22M
    March 31, 2008 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    BIIB Cash from Investing Quarterly Benchmarks

    Companies
    Elan 138.80M
    Novartis 696.00M
    Celgene Corporation -251.50M

    BIIB Cash from Investing Quarterly Rankings

    Overall 98th percentile
    101 of 8005
    Sector 99th percentile
    6 of 686 in Healthcare
    Industry 99th percentile
    2 of 248 in Biotechnology

    BIIB Cash from Investing Quarterly Range, Past 5 Years

    Minimum -587.18M Sep 2011
    Maximum 683.96M Jun 2010
    Average -165.49M